<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(1)</volume><submitter>Zhou S</submitter><funding>Clinical study of a new biomarker cervical cytology screening method p16 series ICC</funding><journal>Discover oncology</journal><pagination>1975</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12559507</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Integrated transcriptomic and immunoinformatics analysis identifies tpx2, bub1b, and ube2c as diagnostic biomarkers and therapeutic targets in endometrial carcinoma.</pubmed_title><pmcid>PMC12559507</pmcid><funding_grant_id>2441ZF036</funding_grant_id><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Zhou S</pubmed_authors><pubmed_authors>Yang M</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Sun J</pubmed_authors><pubmed_authors>Shi X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Integrated transcriptomic and immunoinformatics analysis identifies tpx2, bub1b, and ube2c as diagnostic biomarkers and therapeutic targets in endometrial carcinoma.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-05T09:29:59.448Z</modification><creation>2026-05-15T03:12:22.043Z</creation></dates><accession>S-EPMC12559507</accession><cross_references><pubmed>41144123</pubmed><doi>10.1007/s12672-025-03800-9</doi></cross_references></HashMap>